Company Invites Congressmen to Local EECP Therapy Centers to Educate Them about How Non-Invasive Treatment Can Save the Healthcare System Millions Vasomedical, Inc. ("Vasomedical") (OTC BB: VASO), a ...
WESTBURY, N.Y.--(BUSINESS WIRE)--March 10, 2006--Vasomedical, Inc. (Nasdaq SC: VASO), a leader in the noninvasive treatment and management of cardiovascular diseases, reconfirmed that the majority of ...
WESTBURY, N.Y.--(BUSINESS WIRE)-- Vasomedical, Inc. (“Vasomedical”) (VASO.PK), a global provider of medical devices, today announced the execution of a definitive agreement with Edgary Consultants LLC ...
Westbury, NY - The relief from severe angina achieved by enhanced external counterpulsation (EECP®) is sustained for at least 2 years, according to a press release from Vasomedical Inc, the makers of ...
New Delhi: Cardiovascular diseases (CVDs) remain the leading cause of mortality in India, accounting for nearly 28% of all deaths, according to the World Health Organization (WHO). Alarmingly, the ...
Dr Andrew D Michaels (University of California, San Francisco) and colleagues publish the first experience with repeat EECP in the February 1, 2005 issue of the American Journal of Cardiology, noting, ...
In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest ...
Vasomedical, Inc. (NASDAQSmallCap: VASO), announced today that five major third-party payers in the United Kingdom have expanded their reimbursement structures to include EECP external ...
In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results